354 related articles for article (PubMed ID: 31445112)
21. The science and practice of medication-assisted treatments for opioid dependence.
Pecoraro A; Ma M; Woody GE
Subst Use Misuse; 2012; 47(8-9):1026-40. PubMed ID: 22676570
[TBL] [Abstract][Full Text] [Related]
22. Opioid Use Disorder and Pregnancy.
O'Donnell FT; Jackson DL
Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
[TBL] [Abstract][Full Text] [Related]
23. Update on pharmacotherapy for treatment of opioid use disorder.
Ayanga D; Shorter D; Kosten TR
Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
[TBL] [Abstract][Full Text] [Related]
24. History of Methadone and Buprenorphine Opioid Agonist Therapy Among People Who Died of an Accidental Opioid-Involved Overdose: Rhode Island, January 1, 2018-June 30, 2020.
Hallowell BD; Weidele HR; Daly M; Chambers LC; Scagos RP; Gargano L; McDonald J
Am J Public Health; 2021 Sep; 111(9):1600-1603. PubMed ID: 34410818
[TBL] [Abstract][Full Text] [Related]
25. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
[No Abstract] [Full Text] [Related]
26. Caring for patients with opioid use disorder in the hospital.
Donroe JH; Holt SR; Tetrault JM
CMAJ; 2016 Dec; 188(17-18):1232-1239. PubMed ID: 27647616
[No Abstract] [Full Text] [Related]
27. Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
Carney BL; Hadland SE; Bagley SM
Pediatr Rev; 2018 Jan; 39(1):43-45. PubMed ID: 29292291
[No Abstract] [Full Text] [Related]
28. Prevention of Opioid Overdose.
Babu KM; Brent J; Juurlink DN
N Engl J Med; 2019 Jun; 380(23):2246-2255. PubMed ID: 31167053
[No Abstract] [Full Text] [Related]
29. Recent Advances in the Treatment of Opioid Use Disorder.
Kuppalli S; Seth R; Orhurhu V; Urits I; Kaye AD; Hunter C; Gulati A; Adekoya P; Kaye AM; Jones MR
Curr Pain Headache Rep; 2021 Mar; 25(4):23. PubMed ID: 33693999
[TBL] [Abstract][Full Text] [Related]
30. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
[TBL] [Abstract][Full Text] [Related]
31. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
[TBL] [Abstract][Full Text] [Related]
32. Global opioid agonist treatment: a review of clinical practices by country.
Jin H; Marshall BDL; Degenhardt L; Strang J; Hickman M; Fiellin DA; Ali R; Bruneau J; Larney S
Addiction; 2020 Dec; 115(12):2243-2254. PubMed ID: 32289189
[TBL] [Abstract][Full Text] [Related]
33. Use of Buprenorphine to Treat Opioid Use Disorder.
Bartholow LAM; Pope J
J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
[TBL] [Abstract][Full Text] [Related]
34. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
35. The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.
Stein BD; Gordon AJ; Sorbero M; Dick AW; Schuster J; Farmer C
Drug Alcohol Depend; 2012 Jun; 123(1-3):72-8. PubMed ID: 22093488
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
37. Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges.
Zweben JE; Sorensen JL; Shingle M; Blazes CK
J Addict Med; 2021 Nov-Dec 01; 15(6):454-460. PubMed ID: 33323695
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.
Ling S; Mangaoil R; Cleverley K; Sproule B; Puts M
Drug Alcohol Depend; 2019 Apr; 197():168-182. PubMed ID: 30831429
[TBL] [Abstract][Full Text] [Related]
39. Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids.
Nielsen S; Larance B; Lintzeris N
JAMA; 2017 Mar; 317(9):967-968. PubMed ID: 28267837
[TBL] [Abstract][Full Text] [Related]
40. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
Connery HS
Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
